Glucose dysmetabolism and prognosis in critical illness

被引:28
|
作者
Lazzeri, Chiara [1 ]
Tarquini, Roberto [3 ]
Giunta, Francesco [2 ]
Gensini, Gian Franco [1 ]
机构
[1] Univ Florence, Univ Careggi, Azienda Osped, Intens Cardiac Care Unit,Heart & Vessel Dept, I-50184 Florence, Italy
[2] Univ Pisa, Azienda Osped Pisana, Cattedra Anestesiol & Rianimaz, UO Anestesia & Rianimaz 4, Pisa, Italy
[3] Univ Florence, Univ Careggi, Azienda Osped, Dept Internal Med, I-50184 Florence, Italy
关键词
Hyperglycemia; Critical illness; Insulin resistance; ACUTE MYOCARDIAL-INFARCTION; INTENSIVE INSULIN THERAPY; BLOOD-GLUCOSE; ADMISSION HYPERGLYCEMIA; HOSPITAL MORTALITY; DIABETIC-PATIENTS; ILL PATIENTS; STRESS HYPERGLYCEMIA; IN-VIVO; METABOLISM;
D O I
10.1007/s11739-008-0206-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acute hyperglycemia frequently present in stress conditions, has long been generally accepted as normal, and not thought to be a cause for concern since a moderate hyperglycemia in critically ill adult patients has been thought to be beneficial during the "fight or flight" response to ensure a supply of glucose as a source of energy to organs that do not require insulin for glucose uptake (i.e., the brain and the immune system). However, an increasing body of evidence associates the upon-admission degree and duration of hyperglycemia during critical illness with an adverse outcome. Hyperglycemia should be regarded as a part of the systemic and complex metabolic derangements observed in critical illness in response to stress and inflammation, which can lead, independent of initial disease, to multiorgan dysfunction and death. A tight glycemic control should be constantly pursued and achieved by insulin infusion bearing in mind that the therapeutic target is fighting the systemic inflammatory response and not merely the glucose plasma levels.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 50 条
  • [1] Glucose dysmetabolism and prognosis in critical illness
    Chiara Lazzeri
    Roberto Tarquini
    Francesco Giunta
    Gian Franco Gensini
    Internal and Emergency Medicine, 2009, 4
  • [2] HIV neuropathy and glucose dysmetabolism
    Sheth, S
    Rao, C
    Tselis, A
    Lewis, R
    NEUROLOGY, 2006, 66 (05) : A230 - A230
  • [3] GLUCOSE DYSMETABOLISM AND MEMBRANOUS NEPHROPATHY
    EHRENREICH, T
    GRISHMAN, E
    CHURG, J
    AMERICAN JOURNAL OF PATHOLOGY, 1974, 74 (02): : A33 - A33
  • [4] Expression of glucose transporters in critical illness
    L Langouche
    S Vander Perre
    P Wouters
    G Van den Berghe
    Critical Care, 10 (Suppl 1):
  • [5] Endogenous glucose production in critical illness
    Al-Yousif, Nameer
    Rawal, Sagar
    Jurczak, Michael
    Mahmud, Hussain
    Shah, Faraaz Ali
    NUTRITION IN CLINICAL PRACTICE, 2021, 36 (02) : 344 - 359
  • [6] Endocrine markers of severity and prognosis in critical illness
    Nylén, ES
    Seam, N
    Khosla, R
    CRITICAL CARE CLINICS, 2006, 22 (01) : 161 - +
  • [7] Humoral markers of severity and prognosis of critical illness
    Nylén, ES
    Alarifi, AA
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 15 (04) : 553 - 573
  • [8] Copeptin as a Prognosis Marker in Critical Illness Patients
    Meyer, B.
    Nikfardjam, M.
    Wexberg, P.
    Heinz, G.
    Struck, J.
    Bergmann, A.
    Morgenthaler, N. G.
    Pacher, R.
    Huelsmann, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (1-2) : A8 - A9
  • [9] Contribution of Eating Behaviours to Glucose Dysmetabolism
    Bertoli, Simona
    Leone, Alessandro
    De Amicis, Ramona
    Battezzati, Alberto
    DIABETES, 2018, 67
  • [10] Glucose absorption & gastric emptying in critical illness
    Chapman, M.
    Fraser, R.
    Bryant, L.
    Burgstad, C.
    Bartholomeusz, F.
    Creed, S.
    Russo, A.
    Jones, K.
    Bellon, M.
    Chatterton, B.
    Butler, R.
    Davidson, G.
    Horowitz, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A346 - A346